Sickle cell disease and readmissions rates after lower extremity arthroplasty: a multistate analysis 2007-2014. Academic Article uri icon

Overview

abstract

  • AIM: To compare readmission rates between patients with sickle cell disease (SCD) and non-sickle cell disease undergoing total hip and knee arthroplasty (THA and TKA). METHODS: Identified adult patients who underwent THA or TKA from 2007 to 2014 in California, Florida, New York, Maryland and Kentucky using a multistate database. Outcomes were 30- and 90-day readmission rates, mortality, complications, length of stay and hospital charges. Logistic regression models were used for analysis. RESULTS: Compared with non-sickle cell disease patients following TKA and THA, SCD patients had higher odds of 30- (odds ratio [OR]: 3.79) and 90-day readmissions (OR: 4.15), mortality (OR: 6.54), more complications, longer length of stay, and higher total charges. CONCLUSION: Following TKA and THA, SCD is associated with higher readmissions and worse outcomes.

publication date

  • March 20, 2019

Research

keywords

  • Anemia, Sickle Cell
  • Arthroplasty, Replacement, Hip
  • Arthroplasty, Replacement, Knee
  • Patient Readmission

Identity

Scopus Document Identifier

  • 85064198557

Digital Object Identifier (DOI)

  • 10.2217/cer-2018-0098

PubMed ID

  • 30892071

Additional Document Info

volume

  • 8

issue

  • 6